Patterson Sandra
Known title: SVP, ControllershipCIK: 0001968906
Associated companies
Transaction History
| GILD | ▲ Buy | Option Exercise | 1,952 | — | 3/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 624 | $73K | 3/10/2025 | View on chart |
| GILD | ▲ Buy | Grant | 709 | $0 | 2/4/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 157 | — | 12/13/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 157 | $14K | 12/13/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 408 | $38K | 12/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 901 | — | 12/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 901 | — | 9/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 292 | $24K | 9/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 3,678 | — | 8/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 980 | $72K | 8/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 901 | — | 6/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 255 | $17K | 6/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 790 | $59K | 3/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 748 | — | 3/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,934 | — | 3/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 181 | — | 12/13/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 117 | — | 12/13/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 298 | $25K | 12/13/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 222 | $18K | 12/10/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 518 | — | 12/10/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 519 | — | 9/10/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 149 | $11K | 9/10/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 4,484 | — | 8/10/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 1,306 | $104K | 8/10/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 153 | $12K | 6/10/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 517 | — | 6/10/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,601 | — | 3/10/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,320 | — | 3/10/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 801 | $64K | 3/10/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Gilead Signs $1.9B Deal With Vir For T-Cell Engagers
Gilead Sciences has entered a $1.9 billion partnership with Vir to develop next-generation T-cell engagers, a move aimed at expanding its oncology pipeline. This strategic agreement coincides with the stock reaching record highs as investors show renewed interest in the healthcare sector. The deal provides a new catalyst for the company ahead of its scheduled third-quarter financial results release.
Gilead Signs $1.9B Deal With Vir For T-Cell Engagers. Gilead Sciences has entered a $1.9 billion partnership with Vir to develop next-generation T-cell engagers, a move aimed at expanding its oncology pipeline. This strategic agreement coincides with the stock reaching record highs as investors show renewed interest in the healthcare sector. The deal provides a new catalyst for the company ahead of its scheduled third-quarter financial results release.